OpenFilings

AMGEN INC

Form10-K

Report Period2023-12-31

Date Filed2024-02-14

Time Filed16:23:32

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
DESCRIPTION OF SECURITIES
FORM OF GRANT OF STOCK OPTION AGREEMENT
FORM OF RESTRICTED STOCK UNIT AGREEMENT
FORM OF PERFORMANCE UNIT AGREEMENT
AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM
FIFTH AMENDMENT TO SUPPLEMENTAL RETIREMENT PLAN
FOURTH AMENDMENT TO NONQUALIFIED DEFERRED COMPENSATION PLAN
AGREEMENT BETWEEN AMGEN INC. AND JAMES BRADNER
COLLABORATION AND LICENSE AGREEMENT BETWEEN AMGEN INC. AND CELLTECH R&D LIMITED
AMENDMENT NO 2 TO CELLTECH COLLABORATION AND LICENSE AGREEMENT
LETTER AGREEMENT RE FTE RATES
SUBSIDIARIES OF THE COMPANY
RULE 13A-14(A) CERTIFICATIONS
SECTION 1350 CERTIFICATIONS
POLICY ON RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
Filing on SEC Edgar